March 4, 2011 (Boston, Massachusetts) — In a study designed to explore the potential of several molecules as biomarkers for HIV-mediated cognitive impairment, researchers at John Hopkins University, ...

Some studies have suggested that Alzheimer’s disease biomarker levels may differ by race. Now, researchers led by John Morris and Suzanne Schindler, Washington University, St. Louis, offer a genetic ...

Bottom Line: Cerebral spinal fluid (CSF) levels of β-amyloid 42(Aβ42) are associated with the diagnosis of Alzheimer disease (AD) and (Aβ) accumulation in the brain independent of apolipoprotein E ...

A study spanning 20 years helps nail down the timing of biomarker changes that occur in the period between normal cognition and a diagnosis of sporadic Alzheimer's disease (AD), something that hasn't ...

A large number of studies over the past 20 years have quantified tau protein in the cerebrospinal fluid of people with Alzheimer’s disease, consistently finding elevated levels of tau in AD—such that ...

Neurological disorders affect hundreds of millions of people worldwide, representing a leading cause of death and imposing a significant long-term burden due to years lived with disability. 1 Despite ...

How Is a CSF Glucose Test Done? The most common way to check the glucose in your cerebrospinal fluid is by performing a lumbar puncture, also called a spinal tap. In some cases, your doctor can also ...

Adjunctive treatment with antiinflammatory corticosteroids like dexamethasone increases survival in tuberculosis meningitis. Dexamethasone responsiveness associates with a C/T variant in Leukotriene ...

In a recent study published in Jama Network, researchers investigated the impact of coronavirus disease 2019 (COVID-19) on biomarkers in the cerebrospinal fluid (CSF). Study: Viral Antigen and ...